Literature DB >> 15268788

Gene activation and gene silencing: a subtle equilibrium.

Vincent Quivy1, Claire Calomme, Ann Dekoninck, Dominique Demonte, Françoise Bex, Isabelle Lamsoul, Caroline Vanhulle, Arsène Burny, Carine Van Lint.   

Abstract

The genetic make-up of a cell resides entirely in its DNA. Now that the nucleotide sequence of several genomes has been determined, the major challenging problem is to understand how cell differentiation, proliferation or death are controlled. Major steps include analysis of the determinants of the cell cycle, the unravelling of RNAs and proteins involved in the control of gene expression and the dissection of the protein-destruction machinery. The successive steps to be considered are transcription of RNA on the DNA template, mRNA stabilization or degradation, and mRNA translation and protein localization in the right cell compartment. Gene expression or gene silencing is the result of many DNA-RNA-protein interactions and chromatin is among the key regulators of gene expression. Open chromatin (euchromatin) allows expression of the DNA message. This chromatin structure is generally characterized by the presence on the gene promoters of transcription complexes associated with histone acetyltransferases (HATs). On the contrary, closed chromatin (heterochromatin) is poorly acetylated and more condensed. It contains histone deacetylases (HDACs), potentially associated with DNA methyltransferases (DNMTs). DNMT activity leads to methylation and silencing of the DNA. Thus, a major problem in the field of gene regulation resides in understanding chromatin structure at each promoter, a formidable task for the years to come.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15268788     DOI: 10.1089/1536230041372454

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  5 in total

1.  Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Authors:  Debra Lyon; Lynne Elmore; Noran Aboalela; Jacqueline Merrill-Schools; Nancy McCain; Angela Starkweather; R K Elswick; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2013-04-11       Impact factor: 2.522

2.  DNA affinity binding studies using a fluorescent dye displacement technique: the dichotomy of the binding site.

Authors:  Caitriona B Spillane; Jayden A Smith; Joy L Morgan; F Richard Keene
Journal:  J Biol Inorg Chem       Date:  2007-05-08       Impact factor: 3.358

3.  Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.

Authors:  Makram Merimi; Pavel Klener; Maud Szynal; Yvette Cleuter; Pierre Kerkhofs; Arsène Burny; Philippe Martiat; Anne Van den Broeke
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

4.  Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation.

Authors:  Laurence Colin; Ann Dekoninck; Michal Reichert; Miriam Calao; Makram Merimi; Anne Van den Broeke; Valérie Vierendeel; Yvette Cleuter; Arsène Burny; Olivier Rohr; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2011-09-02       Impact factor: 16.971

5.  Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?

Authors:  Alba Murgia; Elena Veronesi; Olivia Candini; Anna Caselli; Naomi D'souza; Valeria Rasini; Andrea Giorgini; Fabio Catani; Lorenzo Iughetti; Massimo Dominici; Jorge S Burns
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.